Syros Pharmaceuticals, Inc. 13D and 13G filings for Tyme Technologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-13 5:10 pm Purchase | 2022-07-03 | 13D | Tyme Technologies, Inc. TYME | Syros Pharmaceuticals Inc. SYRS | 17,819,723 9.900% | 17,819,723 (New Position) | Filing |